Elanco Animal Health Stock Today
| ELAN Stock | USD 13.53 0.06 0.45% |
Performance0 of 100
| Odds Of DistressLess than 36
|
Elanco Animal is selling at 13.53 as of the 3rd of May 2024; that is 0.45 percent up since the beginning of the trading day. The stock's open price was 13.47. Elanco Animal has about a 36 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Note, on March 6, 2024, Representative Ro Khanna of US Congress acquired under $15k worth of Elanco Animal Health's common stock.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 20th of September 2018 | Category Healthcare | Classification Health Care |
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana. Elanco Animal operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on New York Stock Exchange. The company has 494.1 M outstanding shares of which 15.52 M shares are currently shorted by private and institutional investors with about 4.27 trading days to cover. More on Elanco Animal Health
Follow Valuation Options Odds of Bankruptcy
Financial Report 14th of May 2024
Elanco Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Elanco Animal's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Elanco Animal or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Jeffrey Simmons | ||||
| Thematic Idea | Pharmaceutical Products (View all Themes) | ||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NYSE Composite, ARCA Pharmaceutical, Pharmaceutical Products, Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) | ||||
| Average Analyst Recommendation Analysts covering Elanco Animal report their recommendations after researching Elanco Animal's financial statements, talking to executives and customers, or listening in on Elanco Animal's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Elanco Animal Health. The Elanco consensus assessment is calculated by taking the average forecast from all of the analysts covering Elanco Animal. | |||||
Elanco Animal's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Elanco Animal's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. Elanco Animal's bond ratings measure its overall creditworthiness, which in many ways corresponds to the cost of borrowing for an issuer. These ratings assign a letter grade to all of Elanco Animal's outstanding corporate bonds that indicate their credit quality. We use reports published by private self-sufficient rating services such as Standard & Poor's or Fitch Ratings Inc. to evaluate a bond issuer's financial strength or its ability to pay a bond's principal and interest. Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Elanco Animal's financial leverage. It provides some insight into what part of Elanco Animal's total assets is financed by creditors.
| |||||
Elanco Animal Health (ELAN) is traded on New York Stock Exchange in USA. It is located in 2500 Innovation Way, Greenfield, IN, United States, 46140 and employs 9,300 people. Elanco Animal is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 6.66 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Elanco Animal's market, we take the total number of its shares issued and multiply it by Elanco Animal's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Elanco Animal Health conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 494.1 M outstanding shares of which 15.52 M shares are currently shorted by private and institutional investors with about 4.27 trading days to cover.
Elanco Animal Health currently holds about 463 M in cash with 271 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.98.
Check Elanco Animal Probability Of Bankruptcy
Ownership AllocationElanco Animal holds a total of 494.1 Million outstanding shares. The majority of Elanco Animal Health outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to obtain positions in Elanco Animal Health to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Elanco Animal. Please pay attention to any change in the institutional holdings of Elanco Animal Health as this could imply that something significant has changed or is about to change at the company. Please note that on March 6, 2024, Representative Ro Khanna of US Congress acquired under $15k worth of Elanco Animal Health's common stock.
Check Elanco Ownership Details
Elanco Stock Price Odds Analysis
Contingent on a normal probability distribution, the odds of Elanco Animal jumping above the current price in 90 days from now is about 68.59%. The Elanco Animal Health probability density function shows the probability of Elanco Animal stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.9133 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Elanco Animal will likely underperform. Additionally, elanco Animal Health has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Elanco Animal to move above the current price in 90 days from now is about 68.59 (This Elanco Animal Health probability density function shows the probability of Elanco Stock to fall within a particular range of prices over 90 days) .
Elanco Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Elanco Animal that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Elanco Animal's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Elanco Animal's value.| Instituion | Recorded On | Shares | |
| Geode Capital Management, Llc | 2023-12-31 | 7.3 M | |
| Holocene Advisors, Lp | 2023-09-30 | 6.7 M | |
| Prudential Financial Inc | 2023-12-31 | 6.4 M | |
| Jpmorgan Chase & Co | 2023-12-31 | 6.4 M | |
| Nuveen Asset Management, Llc | 2023-12-31 | 6.1 M | |
| Morgan Stanley - Brokerage Accounts | 2023-12-31 | 6 M | |
| Wellington Management Company Llp | 2023-12-31 | 5.8 M | |
| T. Rowe Price Investment Management,inc. | 2023-12-31 | 5.8 M | |
| Magnetar Financial Llc | 2023-12-31 | 5.8 M | |
| Dodge & Cox | 2023-12-31 | 84 M | |
| Primecap Management Company | 2023-12-31 | 50.6 M |
Elanco Animal Historical Income Statement
Elanco Animal Health Income Statement is one of the three primary financial statements used for reporting Elanco's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Elanco Animal Health revenue and expense. Elanco Animal Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Elanco Animal's Interest Expense is very stable compared to the past year. As of the 3rd of May 2024, EBIT is likely to grow to about 254.7 M, while Tax Provision is likely to drop (13.7 M). View More FundamentalsElanco Stock Against Markets
Picking the right benchmark for Elanco Animal stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Elanco Animal stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Elanco Animal is critical whether you are bullish or bearish towards Elanco Animal Health at a given time. Please also check how Elanco Animal's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Elanco Animal without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Analyst Advice Now
Analyst AdviceAnalyst recommendations and target price estimates broken down by several categories |
| All Next | Launch Module |
Elanco Animal Corporate Directors
Elanco Animal corporate directors refer to members of an Elanco Animal board of directors. The board of directors generally takes responsibility for the Elanco Animal's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Elanco Animal's board members must vote for the resolution. The Elanco Animal board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Joshua Smiley | Independent Director | Profile | |
| Carl McMillian | Independent Director | Profile | |
| Denise ScotsKnight | Independent Director | Profile | |
| Kirk McDonald | Independent Director | Profile |
How to buy Elanco Stock?
Before investing in Elanco Animal, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Elanco Animal. To buy Elanco Animal stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Elanco Animal. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Elanco Animal stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Elanco Animal Health stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Elanco Animal Health stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Elanco Animal Health, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Elanco Stock please use our How to Invest in Elanco Animal guide.
Already Invested in Elanco Animal Health?
The danger of trading Elanco Animal Health is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Elanco Animal is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Elanco Animal. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Elanco Animal Health is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Elanco Animal Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Elanco Animal's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Elanco Animal Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Elanco Animal Health Stock: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Elanco Animal Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Elanco Animal Health information on this page should be used as a complementary analysis to other Elanco Animal's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Complementary Tools for Elanco Stock analysis
When running Elanco Animal's price analysis, check to measure Elanco Animal's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elanco Animal is operating at the current time. Most of Elanco Animal's value examination focuses on studying past and present price action to predict the probability of Elanco Animal's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elanco Animal's price. Additionally, you may evaluate how the addition of Elanco Animal to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
Is Elanco Animal's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Elanco Animal. If investors know Elanco will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Elanco Animal listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.097 | Earnings Share (2.50) | Revenue Per Share 8.972 | Quarterly Revenue Growth 0.051 | Return On Assets 0.0139 |
The market value of Elanco Animal Health is measured differently than its book value, which is the value of Elanco that is recorded on the company's balance sheet. Investors also form their own opinion of Elanco Animal's value that differs from its market value or its book value, called intrinsic value, which is Elanco Animal's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Elanco Animal's market value can be influenced by many factors that don't directly affect Elanco Animal's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Elanco Animal's value and its price as these two are different measures arrived at by different means. Investors typically determine if Elanco Animal is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Elanco Animal's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.